IP Verse

Elkington & Fife patent opposition analysis

The comprehensive analysis of Elkington & Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington & Fife

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3019153	Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation	CHIESI FARMACEUTICI	Jun 5, 2019	TEVA UK
EP2622971	Method For Controlling The Digestive Coagulation Of Proteins	NUTRICIA	Jan 3, 2019	NESTEC
EP1617820	Dry Power Inhaler Devices And Dry Power Formulations For Enhancing Dosing Efficiency	VECTURA	Dec 21, 2018	TEVA UK
EP2286797	Dry Powder Composition Comprising Co-Jet Milled Particles For Pulmonary Inhalation	VECTURA	Dec 14, 2018	TEVA PHARMACEUTICALS
EP1940349	Aerosol Formulation For The Inhalation Of Beta Agonists	BOEHRINGER INGELHEIM	Nov 13, 2018	TEVA UK
EP2865382	Low-Caloric High-Protein Nutritional Composition For The Stimulation Of Muscle Protein Synthesis	NUTRICIA	Oct 17, 2018	NESTEC
EP2393477	Use Of A Glucocorticoid Composition For The Treatment Of Severe And Uncontrolled Asthma	VECTURA	Sep 26, 2018	TEVA PHARMACEUTICALS
EP2687106	High Energy Liquid Enteral Nutritional Composition	NUTRICIA	May 3, 2018	NESTEC
EP2588090	Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts	KRKA	Jan 16, 2018	GENERICS UK
EP2410981	Dry Powder Formulations And Methods For Treating Pulmonary Diseases	PULMATRIX OPERATING	Dec 12, 2017	TEVA PHARMACEUTICALS

Top companies who are the clients of Elkington & Fife